The Ministry of Health and Social Protection reported on December 1, 2025, that HIV prevalence in Morocco remains low in the general adult population (0.08%) but is concentrated among key populations.
– 2.2% among female sex workers
– 5.3% among men who have sex with men
– 5.3% among people who inject drugs
– 4.6% among migrants
Key populations and their partners account for 67% of new HIV infections. By the end of 2024, 66% of reported cases were in the asymptomatic stage. 64% of notifications came from the regions of Casablanca‑Settat, Marrakech‑Safi, and Souss‑Massa.
The estimated number of new infections fell by 22% between 2013 and 2024, according to data from the National AIDS Control Program.
At the same time, the share of people living with HIV (PLHIV) who know their status rose from 49% in 2013 to 80% in 2024.
Among those diagnosed, 95% are now on antiretroviral treatment (ART), underscoring progress in screening and care.
According to the 2019 national seroprevalence survey, the prevalence of hepatitis C was 0.5%, hepatitis B was 0.7%, and hepatitis A was 88% at the national level, though rates are significantly higher among at‑risk populations, reaching 60% among hemodialysis patients and people who inject drugs.
5.3% HIV prevalence among people who inject drugs
Issues related to the use of psychoactive substances are a growing public health problem in Morocco, accounting for 5.55% of all mental disorders and representing nearly 340,000 prevalent cases, according to IHME (2019).
This issue particularly affects young people, with an estimated 1,600 PWID nationwide in 2024. The health situation of this population is alarming:
– HIV prevalence is 5.3% among PWID, compared to 0.08% in the general population
– while hepatitis C (HCV) affects 36.7% of PWID, compared to 0.5% in the rest of the population
